Search

Author/Creator Burdaeva, Olga

1. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. Issue 1 (1st January 2021)

Authors:
Johnston, Stephen R. D.; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F.; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D.; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A.; Williams, Lisa S.; Gradishar, William J.
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 1(2021)
Page Start:
79
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search